Levodropropizine

Levodropropizine is a cough suppressant. It is the levo isomer of dropropizine. It acts as a peripheral antitussive, with no action in the central nervous system.[1] It does not cause side effects such as constipation or respiratory depression which can be produced by opioid antitussives such as codeine and its derivatives.

Levodropropizine

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	R05DB27 (WHO)
Pharmacokinetic data
Protein binding	11-14%
Excretion	83% via urine within 96 h
Identifiers
IUPAC name (2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
CAS Number	99291-25-5
PubChem CID	65859
ChemSpider	59270
UNII	3O31P6T4G3
KEGG	D08119
ChEBI	CHEBI:82722
CompTox Dashboard (EPA)	DTXSID8023210
ECHA InfoCard	100.167.719
Chemical and physical data
Formula	C13H20N2O2
Molar mass	236.315 g·mol^−1
3D model (JSmol)	Interactive image
SMILES O[C@@H](CN2CCN(c1ccccc1)CC2)CO
InChI InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2/t13-/m0/s1 Key:PTVWPYVOOKLBCG-ZDUSSCGKSA-N
(what is this?)  (verify)

References

1. De Blasio F, Dicpinigaitis PV, Rubin BK, De Danieli G, Lanata L, Zanasi A (January 2012). "An observational study on cough in children: epidemiology, impact on quality of sleep and treatment outcome". Cough. 8 (1): 1. doi:10.1186/1745-9974-8-1. PMC 3274450. PMID 22269875.